Voyageur Pharmaceuticals (CVE:VM) Shares Up 21.4% – Time to Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VM) rose 21.4% during trading on Wednesday . The company traded as high as C$0.09 and last traded at C$0.09. Approximately 1,238,946 shares changed hands during mid-day trading, an increase of 1,152% from the average daily volume of 98,928 shares. The stock had previously closed at C$0.07.

Voyageur Pharmaceuticals Stock Up 11.1 %

The company has a market cap of C$13.95 million, a PE ratio of -10.00 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The company’s 50 day moving average is C$0.07 and its 200 day moving average is C$0.06.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.